drugset
drugset / Trial / NCT05204667

Different Dosage Regimens of Methocarbamol/Paracetamol in Acute Non-specific Low Back Pain. MioPain Study

NCT05204667 ↗

Phase 4 Terminated 172 enrolled Angelini Pharma Hippocrates Research · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to evaluate the efficacy and safety of different dosage regimens of the combination methocarbamol/paracetamol in the treatment of patients with acute non-specific Low Back Pain.

Timeline

Start
2021-10-07
Primary completion
2023-11-03
Completion
2024-02-28

Outcome

Outcome not reported

Stopped: “The study had to be closed because it was not feasible to reach the estimated sample size.”

Drugs

EvaluationDrugModalityDoseRoute
Subject 380 mg/300 mg comprimidos metocarbamol/paracetamol - 4 times daily Unknown 380 mg Oral
Subject Acetaminophen Small molecule 300 mg Oral

Indications

No indication recorded.